Opto Circuits (India) Ltd Stock Analysis

BSE: 532391 | NSE: OPTOCIRCUI | Medical Equipment/Supplies/Accessories | Small Cap

BSE Share Price 23-May-2022 18:01
1.78 0.00 (0.00%)

DeciZen - Make an Informed Decision on Opto Circuits (I)

M-Cap below 100cr DeciZen not available

Opto Circuits (I) Price Chart

P/E Ratio ( SA) :
Market Cap :
53.5 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Opto Circuits (India) Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Opto Circuits (India) Ltd is a below average quality company.

2. Is Opto Circuits (India) Ltd undervalued or overvalued?

The key valuation ratios of Opto Circuits (India) Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Opto Circuits (India) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Opto Circuits (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Opto Circuits (I):

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Opto Circuits (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 17.9%14.2%12.5%3.5%-1.3%0.2%-20%0.7%2%-31.2%-
Value Creation Index 0.30.1-0.1-0.8-1.1-1.0-2.4-1.0-0.9-3.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 60367069926314676.750.463.510562.60
YoY Gr. Rt. %-11%4.4%-62.4%-44.4%-47.5%-34.3%26%65.2%-40.3%-
Adj EPS 9.89.7101.8-2.9-0.7-150.31.1-11.6-5.3
YoY Gr. Rt. %--1.4%3.7%-82.1%-263.7%NANANA220.6%-1163.3%-
BVPS (₹) 43.950.16061.85352.336.839.139.11.3-4
Adj Net Profit 23823424343.3-70.9-18-3649.832.7-349-159
Cash Flow from Ops. 118-29.5-92.9-15.755.733557.446.64221.3-
Debt/CF from Ops. 6.1-22.3-8.8-5615.92.112.411.812.623-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -22.3%-15.6%7.5%-40.3%
Adj EPS -201.9%NANA-1163.3%
BVPS -32.4-52.4-67.2-96.7
Share Price -24.2% -29.7% -42.1% -

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 24.720.618.22.9-5.1-1.4-33.712.8-57.4389.7
Op. Profit Mgn % 4041.739.443.736.530.629.831.839.826.9-4905.1
Net Profit Mgn % 39.43534.716.5-48.5-23.5-722.815.531.2-556.7-63493.1
Debt to Equity
Working Cap Days 3756099062,7744,9588,64610,2396,4713,9494,6241,89,400
Cash Conv. Cycle 2342643601,3082,3302,2637344013-1220

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 389.70%

Sales growth has been subdued in last 3 years 7.51%

Debt to equity has increased versus last 3 years average to 12.53

Sales growth is not so good in last 4 quarters at -93.75%

Latest Financials - Opto Circuits (India) Ltd.

Standalone Consolidated
TTM EPS (₹) -5.3 -4.3
TTM Sales (₹ Cr.) 0.3 106
BVPS (₹.) -4 -7.7
Reserves (₹ Cr.) -421 -531
P/BV -0.44 -0.23
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 1.78 / 1.94
All Time Low / High (₹) 1.45 / 262.90
Market Cap (₹ Cr.) 53.5
Equity (₹ Cr.) 300.6
Face Value (₹) 10
Industry PE 49.8

Management X-Ray of Opto Circuits (I) :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Opto Circuits (I)

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Opto Circuits (India) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Opto Circuits (I) on 23-May-2022 18:01 is : 1.78.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-May-2022 18:01 the market cap of Opto Circuits (I) stood at ₹ 53.51.
The latest PE ratio of Opto Circuits (I) as of 23-May-2022 18:01 is 0.00.
The latest PB ratio of Opto Circuits (I) as of 23-May-2022 18:01 is -0.44
The 52-week high of Opto Circuits (I) is ₹ 1.94 and the 52-week low is ₹ 1.78.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Opto Circuits (I) is ₹ 0.25 ( Cr.) .

About Opto Circuits (India) Ltd

Opto Circuits India (OCI), incorporated in the year 1992 is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries. The manufacturing is backed by a complete range of inspection and reliability testing equipments such as Bond Pull, Shear Testers, Stereo Microscopes, IR Viewers Spectrometers and many more.

OCI specialize in cardiac and vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies. Its products are US FDA listed and CE marked. Some of the well-known brands marketed by the company are Criticare Systems, Mediaid, Unetixs Vascular, Eurocor and Cardiac Science.

The company has customers in USA, Europe, Middle East, Far East, South Africa etc. To service these customers it has offices through its subsidiaries in USA, Germany, Singapore and Dubai. It has subsidiaries namely Mediaid Inc (USA), Eurocor Gmbh (Germany), Criticare Systems Inc (USA), Advanced Micronic Devices (India), Devon Innovations (India), ORMED Medical Technology (India) and Altron Industries (India).

It clients includes names like Manipal Groups of hospitals, Escorts Heart Hospital, Wockhardt Heart Hospitals, Apollo Group of Hospitals, Lilavati hospital, Breach Candy Hospital are among others.

In January 2009, the company’s California-based Mediaid Inc., the subsidiary company and the international marketing arm of the company had received Brazilian FDA agency - Agencia Nacional de Vigilancia Sanitaria (ANVISA) - approval for marketing and sale of the Mediaid brand of US FDA-approved Pulse Oximetry (SPO2) products (Patient Monitors & Sensors) in the country and surrounding geographies.

During December, 2010 Opto Circuits (India) has successfully acquired 76% of outstanding common stock of Cardiac Science Corporation US. The company plans to exercise its top-up option under the terms of the merger agreement. The merger is expected to occur in the next few days. Following the merger, Cardiac Science will become a wholly-owned subsidiary of Opto Circuits (India).


Health Care products- Under this segment it manufactures Pulse Oximeters, Pulse Oximeter Sensors, Fluid warmers, Digital Thermometer,Cholesterol Monitors And Stent.

Opto Electronics products- The Company manufactures Infrared Emitters, Infra Red Detectors, Photo Sensor, Detector and Emitter Assemblies.


The company has ISO 9001-2000 and ISO 13485-2003 quality system certification.

OCI has received 2 Star Trading House Status in accordance with the provisions of Exim Policy of Federal Government of India.

Opto Circuits (India) has been featured in Forbes Asia’s 200 ‘Best Under a Billion’ List, 2011 by Forbes magazine. This is the third time the company has made it to this list, the last two times being 2008 and 2009.


- Opto Circuits acquisition of Unetixs Vascular creates strong synergies for Criticare Systems.
- Opto Circuits Successfully Completes Acquisition of Cardiac Science.
- Opto Circuits forays into manufacturing of cardiac stents - acquires Kolkata based N.S. Remedies.

- Opto Circuits presents Bangalore Metro Rail Corporation Ltd. it's first public access defibrillator.
- Opto Circuits launches campaign to promote heart safe environments on World Heart Day.
- Opto Circuits ranked amongst Forbes' Asia's 200 Best Under a Billion companies for third year.

- Opto Circuits launches new Powerheart G5 AED.
- Opto Circuits Supplies AEDs to 2012 UEFA European Football Championship.
- Opto Circuits launches its first Sirolimus Drug Eluting Stent."


Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now